Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

The Impact of Preeclampsia on Gene Expression at the Maternal-Fetal Interface.

Winn VD, Gormley M, Fisher SJ.

Pregnancy Hypertens. 2011 Jan 1;1(1):100-8. doi: 10.1016/j.preghy.2010.12.001.

2.

Pathophysiology of placentation abnormalities in pregnancy-induced hypertension.

Furuya M, Ishida J, Aoki I, Fukamizu A.

Vasc Health Risk Manag. 2008;4(6):1301-13. Review.

3.

Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia--a step forward but not the definitive answer.

Foidart JM, Schaaps JP, Chantraine F, Munaut C, Lorquet S.

J Reprod Immunol. 2009 Nov;82(2):106-11. doi: 10.1016/j.jri.2009.09.001. Epub 2009 Oct 23. Review.

4.

Angiogenic factors in the pathogenesis of preeclampsia.

Yuan HT, Haig D, Ananth Karumanchi S.

Curr Top Dev Biol. 2005;71:297-312. Review.

PMID:
16344109
5.

Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2.

Winn VD, Gormley M, Paquet AC, Kjaer-Sorensen K, Kramer A, Rumer KK, Haimov-Kochman R, Yeh RF, Overgaard MT, Varki A, Oxvig C, Fisher SJ.

Endocrinology. 2009 Jan;150(1):452-62. doi: 10.1210/en.2008-0990. Epub 2008 Sep 25. Review.

6.

Vascular dysfunction in preeclampsia.

Brennan LJ, Morton JS, Davidge ST.

Microcirculation. 2014 Jan;21(1):4-14. doi: 10.1111/micc.12079. Review.

PMID:
23890192
7.

The Impact of Maternal-Fetal Genetic Conflict Situations on the Pathogenesis of Preeclampsia.

Kobayashi H.

Biochem Genet. 2015 Oct;53(9-10):223-34. doi: 10.1007/s10528-015-9684-y. Epub 2015 Jun 25. Review.

PMID:
26109010
8.

Placentation abnormalities in the pathophysiology of preeclampsia.

Cheng MH, Wang PH.

Expert Rev Mol Diagn. 2009 Jan;9(1):37-49. doi: 10.1586/14737159.9.1.37. Review.

PMID:
19099348
9.

Molecular mechanisms of preeclampsia.

Mutter WP, Karumanchi SA.

Microvasc Res. 2008 Jan;75(1):1-8. Epub 2007 May 6. Review.

10.

Placenta-derived angiogenic proteins and their contribution to the pathogenesis of preeclampsia.

Pratt A, Da Silva Costa F, Borg AJ, Kalionis B, Keogh R, Murthi P.

Angiogenesis. 2015 Apr;18(2):115-23. doi: 10.1007/s10456-014-9452-3. Epub 2014 Nov 30. Review.

PMID:
25433512
11.

Preeclampsia: an update.

Lambert G, Brichant JF, Hartstein G, Bonhomme V, Dewandre PY.

Acta Anaesthesiol Belg. 2014;65(4):137-49. Review.

PMID:
25622379
12.

Preeclampsia: the role of angiogenic factors in its pathogenesis.

Wang A, Rana S, Karumanchi SA.

Physiology (Bethesda). 2009 Jun;24:147-58. doi: 10.1152/physiol.00043.2008. Review.

PMID:
19509125
13.

Genetic and epigenetic factors contribute to the onset of preeclampsia.

Chelbi ST, Vaiman D.

Mol Cell Endocrinol. 2008 Jan 30;282(1-2):120-9. doi: 10.1016/j.mce.2007.11.022. Epub 2007 Nov 26. Review.

PMID:
18177994
14.

Angiogenic factors and natural killer (NK) cells in the pathogenesis of preeclampsia.

Kopcow HD, Karumanchi SA.

J Reprod Immunol. 2007 Dec;76(1-2):23-9. Epub 2007 May 9. Review.

15.

Preeclampsia: current understanding of the molecular basis of vascular dysfunction.

Sankaralingam S, Arenas IA, Lalu MM, Davidge ST.

Expert Rev Mol Med. 2006 Jan 26;8(3):1-20. Review.

PMID:
16438753
16.
17.

Preeclampsia and angiogenic imbalance.

Maynard S, Epstein FH, Karumanchi SA.

Annu Rev Med. 2008;59:61-78. Review.

PMID:
17937587
18.

Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia.

Silasi M, Cohen B, Karumanchi SA, Rana S.

Obstet Gynecol Clin North Am. 2010 Jun;37(2):239-53. doi: 10.1016/j.ogc.2010.02.013. Review.

PMID:
20685551
19.

[Preeclampsia as a maternal vascular disease].

Amash A, Huleihel M, Sheiner E, Sapir O, Holcberg G.

Harefuah. 2007 Sep;146(9):707-12, 733. Review. Hebrew.

PMID:
17969310
20.

Supplemental Content

Support Center